Carbonyl stress in aging process: Role of vitamins and phytochemicals as redox regulators

Aging and Disease

Volumn 4, Issue 5, 2013, Pages 276-294

  Ergin, Volkan ^a   Hariry, Reza Ebrahimi ^a   Karasu, Çimen ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Aging; Carbonyl stress; Diseases; Phytochemicals; Redox regulators; Vitamin

Indexed keywords

EID: 84896384613     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2013.0400276     Document Type: Review

References (225)

1. Rattan SI, Ali RE (2007). Hormetic prevention of molecular damage during cellular aging of human skin fibroblasts and keratinocytes. Ann N Y Acad Sci, 1100:424-30.
2. Rattan SI, Kryzch V, Schnebert S, Perrier E, Nizard C (2013). Hormesis-based anti-aging products: a case study of a novel cosmetic. Dose Response, 11:99-108.
3. Streit WJ, Xue QS (2012). Alzheimer's disease, neuroprotection, and CNS immunosenescence. Front Pharmacol, 3:138.
4. Canugovi C, Misiak M, Ferrarelli LK, Croteau DL, Bohr VA (2013). The role of DNA repair in brain related disease pathology. DNA Repair (Amst), 12:578-87.
5. Sykora P, Wilson DM 3rd, Bohr VA (2013). Base excision repair in the mammalian brain: Implication for age related neurodegeneration. Mech Aging Dev, In Press.
6. Branchetti E, Sainger R, Poggio P, Grau JB, Patterson-Fortin J, Bavaria JE, Chorny M, Lai E, Gorman RC, Levy RJ, Ferrari G (2013). Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis. Arterioscler Thromb Vasc Biol, 33:e66-74.
7. Neofytou E, Tzortzaki EG, Chatziantoniou A, Siafakas NM (2012). DNA Damage Due to Oxidative Stress in Chronic Obstructive Pulmonary Disease (COPD). Int J Mol Sci, 13:16853-64.
8. Mangerich A, Bürkle A (2012). Pleiotropic cellular functions of PARP1 in longevity and aging: genome maintenance meets inflammation. Oxid Med Cell Longev, 2012:321653.
9. Höhn A, König J, Grune T (2013). Protein oxidation in aging and the removal of oxidized proteins. J Proteomics, In Press.
10. Butterfield DA, Dalle-Donne I (2012). Redox proteomics. Antioxid Redox Signal, 17:1487-9.
11. Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R (2008). Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol, 153:6-20.
12. Höhn A, Sittig A, Jung T, Grimm S, Grune T (2012). Lipofuscinis formed independently of macroautophagy and lysosomal activity in stress-induced prematurely senescent human fibroblasts. Free Radic Biol Med, 53:1760-9.
13. de Gonzalo-Calvo D, Neitzert K, Fernández M, Vega-Naredo I, Caballero B, García-Macía M, Suárez FM, Rodríguez-Colunga MJ, Solano JJ, Coto-Montes A (2010). Differential inflammatory responses in aging and disease: TNF-alpha and IL-6 as possible biomarkers. Free Radic Biol Med, 49:733-7.
14. Freund A, Orjalo AV, Desprez PY, Campisi J (2010). Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med, 16:238-46.
15. Wang J, Geiger H, Rudolph KL (2011). Immunoaging induced by hematopoietic stem cell aging. Curr Opin Immunol, 23:532-6.
16. Shalev I, Entringer S, Wadhwa PD, Wolkowitz OM, Puterman E, Lin J, Epel ES (2013). Stress and telomere biology: A lifespan perspective. Psychoneuroendocrinology, In Press.
17. Rattan SI (2006). Theories of biological aging: genes, proteins, and free radicals. Free Radic Res, 40:1230-8.
18. Fyhrquist F, Saijonmaa O, Strandberg T (2013). The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol, 10:274-83.
19. Behrens MI, Silva M, Salech F, Ponce DP, Merino D, Sinning M, Xiong C, Roe CM, Quest AF (2013). Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer's patients and skin cancer survivors: increased apoptosis in Alzheimer's and reduced necrosis in cancer. J Gerontol A Biol Sci Med Sci, 67:1036-40.
20. Mirisola MG, Longo VD (2013). A radical signal activates the epigenetic regulation of longevity. Cell Metab, 17:812-3.
21. Park JH, Kim JJ, Bae YS (2013). Involvement of PI3K-AKT-mTOR pathway in protein kinase CKII inhibition-mediated senescence in human colon cancer cells. Biochem Biophys Res Commun, 433:420-5.
22. Kern A, Behl C (2009). The unsolved relationship of brain aging and late-onset Alzheimer disease. Biochim Biophys Acta, 1790:1124-32.
23. Krautwald M, Münch G (2010). Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease? Exp Gerontol, 45:744-51.
24. Watfa G, Dragonas C, Brosche T, Dittrich R, Sieber CC, Alecu C, Benetos A, Nzietchueng R (2011). Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease. J Nutr Health Aging, 15:277-81.
25. Chinta SJ, Lieu CA, Demaria M, Laberge RM, Campisi J, Andersen JK (2013). Environmental stress, aging and glial cell senescence: a novel mechanistic link to Parkinson's disease? J Intern Med, 273:429-36.
26. Paschos A, Pandya R, Duivenvoorden WC, Pinthus JH (2013). Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics. Prostate Cancer Prostatic Dis, In Press.
27. Cabrera MA, de Andrade SM, Mesas AE (2012). A prospective study of risk factors for cardiovascular events among the elderly. Clin Interv Aging. 7:463-8.
28. Zamora PL, Villamena FA (2013). Pharmacological approaches to the treatment of oxidative stress-induced cardiovascular dysfunctions. Future Med Chem, 5:465-78.
29. Terman A, Dalen H, Eaton JW, Neuzil J, Brunk UT (2004). Aging of cardiac myocytes in culture: oxidative stress, lipofuscin accumulation, and mitochondrial turnover. Ann N Y Acad Sci, 1019:70-7.
30. Tsyplenkova VG (2012). Mechanisms of cardiac hystiocyte's aging and death under noncoronary cardiac diseases. Arkh Patol, 74:22-5.
31. Roosimaa M, Põdramägi T, Kadaja L, Ruusalepp A, Paju K, Puhke R, Eimre M, Orlova E, Piirsoo A, Peet N, Gellerich FN, Seppet E (2012). Dilation of human atria: Increased diffusion restrictions for ADP, overexpression of hexokinase 2 and its coupling to oxidative phosphorylation in cardiomyocytes. Mitochondrion, In Press.
32. Marín C, Yubero-Serrano EM, López-Miranda J, Pérez-Jiménez F (2013). Endothelial aging associated with oxidative stress can be modulated by a healthy Mediterranean diet. Int J Mol Sci, 14:8869-89.
33. Barodka VM, Joshi BL, Berkowitz DE, Hogue CWJr, Nyhan D (2011). Review article: implications of vascular aging. Anesth Analg, 112:1048-60.
34. Sakul A, Cumaoglu A, Aydin E, Ari N, Dilsiz N, Karasu C (2013). Age- and diabetes-induced regulation of oxidative protein modification in rat brain and peripheral tissues: consequences of treatment with antioxidant pyridoindole. Exp Gerontol, 48:476-84.
35. Kawashima M, Ozawa Y, Shinmura K, Inaba T, Nakamura S, Kawakita T, Watanabe M, Tsubota K (2013). Calorie restriction (CR) and CR mimetics for the prevention and treatment of age-related eye disorders. Exp Gerontol. In Press.
36. Lim XL, Teo BW, Tai BC, Wong TY, Ng DP (2012). Pentosidine levels in nonproteinuric diabetes associated with both low estimated glomerular filtration rate and cataract. Diabetes Metab Syndr Obes, 5:155-64.
37. Danoux L, Mine S, Abdul-Malak N, Henry F, Jeanmaire C, Freis O, Pauly G, Cittadini L, André-Frei V, Rathjens A (2013). How to help the skin cope with glycoxidation. Clin Chem Lab Med, 2:1-8.
38. Ganceviciene R, Liakou AI, Theodoridis A, Makrantonaki E, Zouboulis CC (2012). Skin anti-aging strategies. Dermatoendocrinol, 4:308-19.
39. Samaras N, Samaras D, Frangos Lordos E, Forster A, Philippe J (2013). A review of age related dehydroepiandrosterone (DHEA) decline and its association with well-known geriatric syndromes. Is treatment beneficial? Rejuvenation Res. In Press.
40. Junnila RK, List EO, Berryman DE, Murrey JW, Kopchick JJ (2013). The GH/IGF-1 axis in aging and longevity. Nat Rev Endocrinol, 9:366-76.
41. Ceylan A, Karasu C, Aktan F, Güven C, Can B, Ozansoy G (2003). Effects of simvastatin treatment on oxidant/antioxidant state and ultrastructure of diabetic rat myocardium. Gen Physiol Biophys, 22:535-47.
42. Uluoglu C, Durakoglugil DB, Karasu C, Ozbey G, Gunes A, Zengil H (2007). The effect of experimental diabetes on the twenty-four-hour pattern of the vasodilator responses to acetylcholine and isoprenaline in the rat aorta. Chronobiol Int, 24:1081-94.
43. Fan X, Sell DR, Zhang J, Nemet I, Theves M, Lu J, Strauch C, Halushka MK, Monnier VM (2010). Anaerobic vs aerobic pathways of carbonyl and oxidant stress in human lens and skin during aging and in diabetes: A comparative analysis. Free Radic Biol Med, 49:847-56.
44. Heimfarth L, Loureiro SO, Pierozan P, de Lima BO, Reis KP, Torres EB, Pessoa-Pureur R (2013). Methylglyoxal-induced cytotoxicity in neonatal rat brain: a role for oxidative stress and MAP kinases. Metab Brain Dis. In Press.
45. Kalyani RR, Egan JM (2013). Diabetes and altered glucose metabolism with aging. Endocrinol Metab Clin North Am, 42:333-47.
46. Murray DB, Haynes K, Tomita M (2011). Redox regulation in respiring Saccharomyces cerevisiae. Biochim Biophys Acta, 1810:945-58.
47. Cai Z, Yan LJ (2013). Protein Oxidative Modifications: Beneficial Roles in Disease and Health. J Biochem Pharmacol Res, 1:15-26.
48. Ristow M, Zarse K (2010). How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis). Exp Gerontol, 45:410-8.
49. Ristow M, Schmeisser S (2011). Extending life span by increasing oxidative stress. Free Radic Biol Med, 51:327-36.
50. Lozins'ka LM, Semchyshyn HM (2012). Biological aspects of non-enzymatic glycosylation. Ukr Biokhim Zh, 84:16-37.
51. Onyango AN (2012). Small reactive carbonyl compounds as tissue lipid oxidation products; and the mechanisms of their formation thereby. Chem Phys Lipids, 165:777-86.
52. Miyazawa T, Nakagawa K, Shimasaki S, Nagai R (2012). Lipid glycation and protein glycation in diabetes and atherosclerosis. Amino Acids, 42:1163-70.
53. Neves D, (2013). Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction. Free Radic Res, In Press.
54. Ulrich P, Cerami A (2001). Protein glycation, diabetes, and aging. Recent Prog Horm Res, 56:1-821.
55. Arsov S, Graaff R, van Oe veren W, Stegmayr B, Sikole A, Rakhorst G, Smit AJ (2013). Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review. Clin Chem Lab Med, 4:1-10.
56. Lo Pachin RM, Gavin T, Petersen DR, Barber DS (2009). Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem Res Toxicol, 22:1499-1508.
57. Karasu C (2010). Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment. Open Cardiovasc Med J, 4:240-256.
58. Baraibar MA, Liu L, Ahmed EK, Friguet B (2012). Protein oxidative damage at the crossroads of cellular senescence, aging, and age-related diseases. Oxid Med Cell Longev, 2012:919832.
59. Nakamura T, Cho DH, Lipton SA (2012). Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases. Exp Neurol, 238:12-21.
60. Liochev SI (2013). Reactive oxygen species and the free radical theory of aging. Free Radic Biol Med, 60:1-4.
61. Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H (2007). Circulating glycotoxins and dietary advanced glycation end products: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci, 62:427-33.
62. Arai M, Miyashita M, Ichikawa T, Itokawa M (2012). Carbonyl stress-related schizophrenia-perspective on future therapy and hypotheses regarding pathophysiology of schizophrenia. Seishin Shinkeigaku Zasshi, 114:199-208.
63. Yanar K, Aydin S, Cakatay U, Mengi M, Buyukpinarbasili N, Atukeren P, Sitar ME, Sönmez A, Uslu E (2011). Protein and DNA oxidation in different anatomic regions of rat brain in a mimetic aging model. Basic Clin Pharmacol Toxicol, 109:423-33.
64. Cumaoglu A, Stefek M, Bauer V, Ari N, Aricioglu A, Karasu C (2010). Glycoxidative and nitrosative stress in kidney of experimental diabetic rats: effects of the prydoindole antioxidant stobadine. Neuro Endocrinol Lett, 31:313-8.
65. Hamelin M, Borot-Laloi C, Friguet B, Bakala H (2003). Increased level of glycoxidation product N(epsilon)-(carboxymethyl)lysine in rat serum and urine proteins with aging: link with glycoxidative damage accumulation in kidney. Arch Biochem Biophys, 411:215-22.
66. Pekiner B, Ulusu NN, Das-Evcimen N, Sahilli M, Aktan F, Stefek M, Stolc S, Karasu C (2002). Antioxidants in Diabetes-Induced Complications Study Group. In vivo treatment with stobadine prevents lipid peroxidation, protein glycation and calcium overload but does not ameliorate Ca2+-ATPase activity in heart and liver of streptozotocin-diabetic rats: comparison with vitamin E. Biochim Biophys Acta, 1588:71-8.
67. Cumaoglu A, Ozansoy G, Irat AM, Aricioglu A, Karasu C, Ari N (2011). Effect of long term, non-cholesterol lowering dose of fluvastatin treatment on oxidative stress in brain and peripheral tissues of streptozotocin-diabetic rats. Eur J Pharmacol, 654:80-5.
68. Ulusu NN, Sahilli M, Avci A, Canbolat O, Ozansoy G, Ari N, Bali M, Stefek M, Stolc S, Gajdosik A, Karasu C (2003). Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effects of stobadine and vitamin E. Neurochem Res, 28:815-23.
69. Muteliefu G, Shimizu H, Enomoto A, Nishijima F, Takahashi M, Niwa T (2012). Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelaminA through oxidative stress. Am J Physiol Cell Physiol, 303:C126-34.
70. Cumaoglu A, Cevik C, Rackova L, Ari N, Karasu C (2007). Effects of antioxidant stobadineon protein carbonylation, advanced oxidation protein products and reductive capacity of liver instreptozotocin-diabetic rats: role of oxidative/nitrosative stress. Biofactors, 30:171-8.
71. Gradinaru D, Borsa C, Ionescu C, Margina D (2013). Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes. J Proteomics. In Press.
72. Sebeková K, Klenovicsová K, Ferenczová J, Hedvig J, Podracká L, Heidland A (2012). Advanced oxidation protein products and advanced glycation end products in children and adolescents with chronic renal insufficiency. J Ren Nutr, 22:143-8.
73. Song BJ, Abdelmegeed MA, Henderson LE, Yoo SH, Wan J, Purohit V, Hardwick JP, Moon KH (2013). Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic Fatty liver disease. Oxid Med Cell Longev, 2013:781050.
74. Jiao L, Taylor PR, Weinstein SJ, Graubard BI, Virtamo J, Albanes D, Stolzenberg-Solomon RZ (2011). Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 20:1430-8.
75. Rahmadi A, Steiner N, Münch G (2011). Advanced glycation end products as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease. Clin Chem Lab Med, 49:385-91.
76. Fanelli F, Sepe S, D'Amelio M, Bernardi C, Cristiano L, Cimini A, Cecconi F, Ceru' MP, Moreno S (2013). Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease. Mol Neurodegener, 8:8.
77. Tan KC, Shiu SW, Wong Y, Tam X (2011). Serum advanced glycation end products (AGEs)are associated with insulin resistance. Diabetes Metab Res Rev, 27:488-92.
78. Vlassara H, Striker G (2007). Glycotoxins in the diet promote diabetes and diabetic complications. Curr Diab Rep, 7:235-41.
79. Jack M, Wright D (2012). Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy. Transl Res,159:355-65.
80. Babizhayev MA, Yegorov YE (2010). Therapeutic uses of drug-carrier systems for imidazole-containing dipeptide compounds that act as pharmacological chaperones and have significant impact on the treatment of chronic diseases associated with increased oxidative stress and the formation of advanced glycation end products. Crit Rev Ther Drug Carrier Syst, 27:85-154.
81. Freund-Michel V, Guibert C, Dubois M, Courtois A, Marthan R, Savineau JP, Muller B (2013). Reactive oxygen species as therapeutic targets in pulmonary hypertension. Ther Adv Respir Dis, 7:175-200.
82. Sell DR, Monnier VM (2012). Molecular basis of arterial stiffening: role of glycation - a mini-review. Gerontology, 58:227-37.
83. Ceylan A, Karasu C, Aktan F, Ozansoy G (2004). Simvastatin treatment restores vasoconstriction and the inhibitory effect of LPC on endothelial relaxation via affecting oxidizing metabolism in diabetic rats. Diabetes Nutr Metab, 17:203-10.
84. Bartosz G. Reactive oxygen species: destroyers or messengers? (2009). Biochem Pharmacol. 77:1303-15.
85. Brieger K, Schiavone S, Miller FJ Jr, Krause KH (2012). Reactive oxygen species: from health to disease. Swiss Med Wkly, 142:w13659.
86. Pi J, Collins S (2010). Reactive oxygen species and uncoupling protein 2 in pancreatic ß-cell function. Diabetes Obes Metab, 12 (Suppl 2):141-8.
87. Racková L, Cumaoglu A, Bagriacik EU, Štefek M, Maechler P, Karasu C (2011). Novel hexahydropyridoindole derivative as prospective agent against oxidative damage in pancreatic ß cells. Med Chem, 7:711-7.
88. Cumaoglu A, Ari N, Kartal M, Karasu C (2011). Polyphenolic extracts from Olea europea L. protect against cytokine-induced ß-cell damage through maintenance of redox homeostasis. Rejuvenation Res, 14:325-34.
89. Cumaoglu A, Rackova L, Stefek M, Kartal M, Maechler P, Karasu C (2011). Effects of olive leaf polyphenols against H2O2 toxicity in insulin secreting ß-cells. Acta Biochim Pol, 58:45-50.
90. Teodoro JS, Rolo AP, Palmeira CM (2013). The NAD ratio redox paradox: why does too much reductive power cause oxidative stress? Toxicol Mech Methods. 23:297-302.
91. Fleury C, Mignotte B, Vayssière JL (2002). Mitochondrial reactive oxygen species in cell death signaling. Biochimie, 84:131-41.
92. Lopaczynski W, Zeisel SH (2001). Antioxidants, programmed cell death, and cancer, Nutrition Research, 21:295-307.
93. Orrenius S, Gogvadze V, Zhivotovsky B (2007) Mitochondrial oxidative stress: implications for cell death, Annu Rev Pharmacol Toxicol, 47:143-83.
94. Gaziano JM, Manson JE, Buring JE, Hennekens CH (1992). Dietary antioxidants and cardiovascular disease. Ann N Y Acad Sci, 669:249-58.
95. Grune T (2000). Oxidative stress, aging and the proteasomal system. Biogerontology, 1:31-40.
96. Zobali F, Avci A, Canbolat O, Karasu C (2002). Effects of vitamin A and insulin on the antioxidative state of diabetic rat heart: a comparison study with combination treatment, Cell Biochem Funct, 20:75-80.
97. Sun AY, Wang Q, Simonyi A, Sun GY (2008). Botanical phenolics and brain health. Neuromolecular Med, 10:259-74.
98. Chandra J, Samali A, Orrenius S (2000). Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med, 29:323-33.
99. Taverna M, Marie AL, Mira JP, Guidet B (2013). Specific antioxidant properties of human serum albumin. Ann Intensive Care, 3:4.
100. Liu RH (2013). Health-promoting components of fruits and vegetables in the diet. Adv Nutr, 4:384S-92S.
101. Eicker J, Kürten V, Wild S, Riss G, Goralczyk R, Krutmann J, Berneburg M (2003). Betacarotene supplementation protects from photoaging-associated mitochondrial DNA mutation. Photochem Photobiol Sci, 2:655-9.
102. Ge XX, Xing MY, Yu LF, Shen P (2013). Carotenoid Intake and Esophageal Cancer Risk: a Meta-analysis. Asian Pac J Cancer Prev, 14:1911-8.
103. Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, Bamlet WR, de Andrade M, Oberg AL, Rabe KG, Anderson KE, Olson JE, Sinha R, Petersen GM (2013). Nutrients from fruit and vegetable consumption reduce the risk of pancreatic cancer. J Gastrointest Cancer, 44:152-61.
104. Ames BN, Shigenaga MK, Hagen TM (1993). Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A, 90:7915-22.
105. (2013). [The influence of combined treatment on biochemical and functional characteristics in the patients with vascular complications of type 1 diabetes mellitus and different quality of compensation]. Klin Med (Mosk), 91:14-8.
106. Yoneda T, Tomofuji T, Ekuni D, Azuma T, Endo Y, Kasuyama K, Machida T, Morita M (2013). Anti-aging Effects of Co-enzyme Q10 on Periodontal Tissues. J Dent Res. 92:735-9.
107. La Guardia PG, Alberici LC, Ravagnani FG, Catharino RR, Vercesi AE (2013). Protection of rat skeletal muscle fibers by either L-carnitine or coenzyme Q10 against statins toxicity mediated by mitochondrial reactive oxygen generation. Front Physiol, 4:103.
108. Shetty RA, Forster MJ, Sumien N (2012). Coenzyme Q(10) supplementation reverses age-related impairments in spatial learning and lowers protein oxidation. Age (Dordr). In Press.
109. Hünkar T, Aktan F, Ceylan A, Karasu C (2002). Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. Effects of cod liver oil on tissue antioxidant pathways in normal and streptozotocin diabetic rats. Cell Biochem Funct, 20: 297-302.
110. Ceylan-Isik A, Hünkar T, Asan E, Kaymaz F, Ari N, Söylemezoglu T, Renda N, Soncul H, Bali M, Karasu C (2007) (Antioxidants in Diabetes-Induced Complications) The ADIC Study Group. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats. J Pharm Pharmacol, 59:1629-41.
111. Saitoh Y, Morishita A, Mito S, Tsujiya T, Miwa N (2013). Senescence-induced increases in intracellular oxidative stress and enhancement of the need for ascorbic acid in human fibroblasts. Mol Cell Biochem. 380:129-41.
112. Iwama M, Amano A, Shimokado K, Maruyama N, Ishigami A (2012). Ascorbic acid levels in various tissues, plasma and urine of mice during aging. J Nutr Sci Vitaminol (Tokyo), 58(3):169-74.
113. Koçak G, Karasu C (2002). Elimination of superoxide/H2O2 by alpha-lipoic acid mediates the recovery of basal EDRF/NO availability and the reversal of superoxide dismutase-induced relaxation in diabetic rat aorta. Diabetes Obes Metab, 4:69-74
114. Koçak G, Aktan F, Canbolat O, Ozogul C, Elbeg S, Yildizoglu-Ari N, Karasu C (2000). ADIC Study Group. Antioxidants in Diabetes-Induced Complications. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr Metab, 13:308-18.
115. Bojunga J, Nowak D, Mitrou PS, Hoelzer D, Zeuzem S, Chow KU (2004). Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic rats. Diabetologia, 47:2072-80.
116. Thakurta IG, Chattopadhyay M, Ghosh A, Chakrabarti S (2012). Dietary supplementation with N-acetyl cysteine, a-tocopherol and a-lipoic acid reduces the extent of oxidative stress and proinflammatory state in aged rat brain. Biogerontology, 13:479-88.
117. Asha Devi S, Manjula KR, Subramanyam MV (2012). Protective role of vitamins E and C against oxidative stress caused by intermittent cold exposure in aging rat's frontoparietal cortex. Neurosci Lett, 529:155-60.
118. Kucukatay V, Bor-Kucukatay M, Gundogdu G, Erken G, Ozcan TO, Miloglu FD, Kadioglu Y (2012). Vitamin E treatment enhances erythrocyte deformability in aged rats. Folia Biol (Praha), 58:157-65.
119. Schmid TE, Eskenazi B, Marchetti F, Young S, Weldon RH, Baumgartner A, Anderson D, Wyrobek AJ (2012). Micronutrients intake is associated with improved sperm DNA quality in older men. Fertil Steril, 98:1130-7.e1.
120. Thiagarajan R, Manikandan R. Antioxidants and cataract (2013). Free Radic Res, 47:337-45.
121. Zarogoulidis P, Cheva A, Zarampouka K, Huang H, Li C, Huang Y, Katsikogiannis N, Zarogoulidis K, (2013). Tocopherols and tocotrienols as anticancer treatment for lung cancer: future nutrition. J Thorac Dis. 5:349-52.
122. Dysken MW, Guarino PD, Vertrees JE, Asthana S, Sano M, Llorente M, Pallaki M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Carney S, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnell KA, Gordon K, Tomaska J, Vatassery G (2013). Vitamin E and memantine in Alzheimer's disease: Clinical trial methods and baseline data. Alzheimers Dement. In Press.
123. Karasu C, Dewhurst M, Stevens EJ, Tomlinson DR (1995). Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia, 38:129-34.
124. Skalska S, Kyselova Z, Gajdosikova A, Karasu C, Stefek M, Stolc S (2008). Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E. Gen Physiol Biophys, 27:106-14.
125. Yülek F, Or M, Ozogul C, Isik AC, Ari N, Stefek M, Bauer V, Karasu C (2007). Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stress. Arch Med Res, 38:503-11.
126. Günes A, Ceylan A, Sarioglu Y, Stefek M, Bauer V, Karasu C (2005). Antioxidants in Diabetes-induced Complications (ADIC) Study Group. Reactive oxygen species mediate abnormal contractile response to sympathetic nerve stimulation and noradrenaline in the vas deferens of chronically diabetic rats: effects of in vivo treatment with antioxidants. Fundam Clin Pharmacol, 19:73-9.
127. Dogru Pekiner B, Das Evcimen N, Ulusu NN, Bali M, Karasu C (2003). Effects of vitamin E on microsomal Ca2+-ATPase activity and calcium levels in streptozotocin-induced diabetic rat kidney. Cell Biochem Funct, 21:177-82.
128. Demiryürek AT, Karasu C, Stefek M, Stolc S (2004). Effect of stobadine on leukocyte free radical generation in streptozotocin-diabetic rats: comparison with vitamin E. Pharmacology, 70:1-4.
129. Das Evcimen N, Ulusu NN, Karasu C, Dogru B (2004). Adenosine triphosphatase activity of streptozotocin-induced diabetic rat brain microsomes. Effect of vitamin E. Gen Physiol Biophys, 23:347-55.
130. Karasu C, Ozansoy G, Bozkurt O, Erdogan D, Omeroglu S (1997). Changes in isoprenaline-induced endothelium-dependent and -independent relaxations of aorta in long-term STZ-diabetic rats: reversal effect of dietary vitamin E. Gen Pharmacol, 29:561-7.
131. Karasu C, Ozansoy G, Bozkurt O, Erdogan D, Omeroglu S (1997). Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. Metabolism, 46:872-9.
132. Suganuma K, Nakajima H, Ohtsuki M, Imokawa G (2010). Astaxanthin attenuates the UVA-induced up-regulation of matrix-metalloproteinase-1 and skin fibroblast elastase in human dermal fibroblasts. J Dermatol Sci, 58:136-42.
133. Glossmann H (2011). Vitamin D, UV, and skin cancer in the elderly: to expose or not to expose? Gerontology, 57:350-3.
134. Reichrath J (2012). Unravelling of hidden secrets: The role of vitamin D in skin aging. Dermatoendocrinol, 4:241-4.
135. Najmi Varzaneh F, Sharifi F, Hossein-Nezhad A, Mirarefin M, Maghbooli Z, Ghaderpanahi M, Larijani B, Fakhrzadeh H (2013). Association of vitamin d receptor with longevity and healthy aging. Acta Med Iran, 51:236-41.
136. Chopra A, Doiphode VV (2002). Ayurvedic medicine. Core concept, therapeutic principles, and current relevance. Med Clin North Am, 86:75-89, vii.
137. Stevensen C (1999). JAMU: an Indonesian herbal tradition with a long past, a little known present and an uncertain future. Complement Ther Nurs Midwifery, 5:1-3.
138. Hosseinzadeh H, Nassiri-Asl M (2013). Avicenna's (Ibn Sina) the Canon of Medicine and saffron (Crocus sativus): a review. Phytother Res, 27:475-83.
139. Rackova L, Snirc V, Jung T, Stefek M, Karasu C, Grune T (2009). Metabolism-induced oxidative stress is a mediator of glucose toxicity in HT22 neuronal cells. Free Radic Res, 43:876-86.
140. Murakami A (2013). Modulation of protein quality control systems by food phytochemicals. J Clin Biochem Nutr, 52:215-27.
141. Stefek M, Karasu C (2011). Eye lens in aging and diabetes: effect of quercetin. Rejuvenation Res, 14:525-34.
142. Scalbert A, Johnson IT, Saltmarsh M (2005). Polyphenols: antioxidants and beyond. Am J Clin Nutr, 81(1 Suppl):215S-217S.
143. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L (2004). Polyphenols: food sources and bioavailability. Am J Clin Nutr, 79:727-47.
144. Sajithlal GB, Chithra P, Chandrakasan G (1998). Effect of curcuminon the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol, 56:1607-14.
145. Yamaguchi F, Ariga T, Yoshimura Y, Nakazawa H (2000). Antioxidative and anti-glycation activity of garcinol from Garcinia indica fruit rind. J Agric Food Chem, 48:180-5.
146. Kim HY, Kim K (2003). Protein glycation inhibitory and antioxidative activities of some plant extracts in vitro. J Agric Food Chem, 51:1586-91.
147. Tung YT, Wu JH, Kuo YH, Chang ST (2007). Antioxidant activities of natural phenolic compounds from Acacia confusa bark. Bioresour Technol, 98:1120-3.
148. Nichols JA, Katiyar SK (2010). Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Arch Dermatol Res, 302:71-83.
149. Korac RR, Khambholja KM (2011). Potential of herbs in skin protection from ultraviolet radiation. Pharmacogn Rev, 5:164-73.
150. Sumbul S, Ahmad MA, Mohd A, Mohd A (2011). Role of phenolic compounds in peptic ulcer: An overview. J Pharm Bioallied Sci, 3:361-7.
151. Middleton E Jr, Kandaswami C, Theoharides TC, (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 52:673-751.
152. Chang CC, Chang CY, Huang JP, Hung LM (2012). "Effect of resveratrol on oxidative and inflammatory stress in liver and spleen of streptozotocin-induced type 1 diabetic rats". Chin J Physiol, 55:192-201.
153. Kesherwani V, Atif F, Yousuf S, Agrawal SK (2013). Resveratrol protects spinal cord dorsal column from hypoxic injury by activating Nrf-2. Neuroscience, 241:80-8.
154. Díaz-Chávez J, Fonseca-Sánchez MA, Arechaga-Ocampo E, Flores-Pérez A, Palacios-Rodríguez Y, Domínguez-Gómez G, Marchat LA, Fuentes-Mera L, Mendoza-Hernández G, Gariglio P, López-Camarillo C (2013). Proteomic Profiling Reveals That Resveratrol Inhibits HSP27 Expression and Sensitizes Breast Cancer Cells to Doxorubicin Therapy. PLoS One, 8:e64378.
155. Avila PR, Marques SO, Luciano TF, Vitto MF, Engelmann J, Souza DR, Pereira SV, Pinho RA, Lira FS, De Souza CT (2013). Resveratrol and fish oil reduce catecholamine-induced mortality in obese rats: role of oxidative stress in the myocardium and aorta. Br J Nutr, 4:1-11.
156. Mohar DS, Malik S (2012). The Sirtuin System: The Holy Grail of Resveratrol? J Clin Exp Cardiolog, 3(11), pii: 216.
157. Mukherjee S, Lekli I, Gurusamy N, Bertelli AA, Das DK (2009). Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radic Biol Med, 46:573-8.
158. Aggarwal BB, Sundaram C, Malani N, Ichikawa H (2007). Curcumin: the Indian solid gold. Adv Exp Med Biol, 595:1-75.
159. Gupta SC, Prasad S, Kim JH, Patchva S, Webb LJ, Priyadarsini IK, Aggarwal BB (2011). Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep, 28:1937-55.
160. Han J, Pan XY, Xu Y, Xiao Y, An Y, Tie L, Pan Y, Li XJ (2012). Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage. Autophagy, 8:812-25.
161. Rattan SI (2008). Hormesis in aging. Aging Res Rev, 7:63-78.
162. Rattan SI, Fernandes RA, Demirovic D, Dymek B, Lima CF (2009). Heat stress and hormetin-induced hormesis in human cells: effects on aging, wound healing, angiogenesis, and differentiation. Dose Response, 7:90-103.
163. Rattan SI (2012). Rationale and methods of discovering hormetins as drugs for healthy aging. Expert Opin Drug Discov. 7:439-48.
164. Colín-González AL, Santana RA, Silva-Islas CA, Chánez-Cárdenas ME, Santamaría A, Maldonado PD (2012). The antioxidant mechanisms underlying the aged garlic extract-and S-allylcysteine-induced protection. Oxid Med Cell Longev, 2012:907162.
165. Du Y, Villeneuve NF, Wang XJ, Sun Z, Chen W, Li J, Lou H, Wong PK, Zhang DD (2008). Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response. Environ Health Perspect, 116:1154-61.
166. Bahadoran Z, Mirmiran P, Azizi F (2013). Potential efficacy of broccoli sprouts as a unique supplement for management of type 2 diabetes and its complications. J Med Food, 16:375-82.
167. Yamabe N, Kang KS, Goto E, Tanaka T, Yokozawa T (2007). Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in Streptozotocin-treated diabetic rats. Biol Pharm Bull, 30:520-6.
168. Jang DS, Lee GY, Kim YS, Lee YM, Kim CS, Yoo JL, Kim JS (2007). Anthraquinones from the seeds of Cassiatora with inhibitory activity on protein glycation and aldose reductase. Biol Pharm Bull, 30:2207-10.
169. Madsen-Bouterse SA, Kowluru RA (2008). Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord, 9:315-27.
170. Karasu C, Cumaoglu A, Gürpinar AR, Kartal M, Kovacikova L, Milackova I, Stefek M (2012). Aldose reductase inhibitory activity and antioxidant capacity of pomegranate extracts. Interdiscip Toxicol, 5:15-20.
171. Gacche RN, Dhole NA (2011). Profile of aldose reductase inhibition, anti-cataract and free radical scavenging activity of selected medicinal plants: an attempt to standardize the botanicals for amelioration of diabetes complications. Food Chem Toxicol, 49:1806-13.
172. Duraisamy Y, Gaffney J, Slevin M, Smith CA, Williamson K, Ahmed N (2003). Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advanced glycation end products and glycated basic fibroblast growth factor in cultured bovine aortic endothelial cells: comparison with aminoguanidine. Mol Cell Biochem, 246:143-53.
173. Xi M, Hai C, Tang H, Chen M, Fang K, Liang X (2008). Antioxidant and antiglycation properties of total saponins extracted from traditional Chinese medicine used to treat diabetes mellitus. Phytother Res, 22:228-37.
174. Illien-Junger S, Grosjean F, Laudier DM, Vlassara H, Striker GE, Iatridis JC (2013). Combined Anti-Inflammatory and Anti-AGE Drug Treatments Have a Protective Effect on Intervertebral Discs in Mice with Diabetes. Plo S One, 8:e64302.
175. Dong Q, Banaich MS, O'Brien PJ (2010). Cytoprotection by almond skin extracts or catechins of hepatocyte cytotoxicity induced by hydroperoxide (oxidative stress model) versus glyoxal or methylglyoxal (carbonylationmodel). Chem Biol Interact, 185:101-9.
176. Peng X, Cheng KW, Ma J, Chen B, Ho CT, Lo C, Chen F, Wang M (2008). Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation end products. J Agric Food Chem, 56:1907-11.
177. Zhu Q, Zheng ZP, Cheng KW, Wu JJ, Zhang S, Tang YS, Sze KH, Chen J, Chen F, Wang M (2009). Natural polyphenols as direct trapping agents of lipid peroxidation-derived acrolein and 4-hydroxy-trans-2-nonenal.ChemResToxicol, 22:1721-7.
178. Lo CY, Hsiao WT, Chen XY (2011). Efficiency of trapping methylglyoxal by phenols and phenolic acids. J Food Sci, 76:H90-6.
179. Dogan I, Cumaoglu A, Aricioglu A, Ekmekci A (2011). Inhibition of ErbB2 by herceptin reduces viability and survival, induces apoptosis and oxidative stress in Calu-3 cell line. Mol Cell Biochem, 347:41-51.
180. Rackova L, Cumaoglu M, Kartal M, Stefek M, Karasu C (2008). Protection of insulin-producing INS-1 cells from H2O2-induced oxidative stress by phenolic extracts from olea europea L. Free Radic Res, 42(Supplement 1): S98.
181. Cumaoglu A, Rackova L, Kartal M, Karasu C (2008). Effects of olive extracts on free radical metabolism and glucose stimulated insulin release in INS-1E cell line exposed to H2O2. FEBS Journal, 275(Supplement 1):377.
182. Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, Hori M (1999). Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes, 48:2398-406.
183. Lortz S, Tiedge M (2003). Sequential inactivation of reactive oxygen species by combined overexpression of SOD isoforms and catalase in insulin-producing cells, Free Radical Biology and Medicine, 34:683-688
184. Hamaoka R, Fujii J, Miyagawa J, Takahashi M, Kishimoto M, Moriwaki M, Yamamoto K, Kajimoto Y, Yamasaki Y, Hanafusa T, Matsuzawa Y, Taniguchi N (1999). Overexpression of the aldose reductase gene induces apoptosis in pancreatic beta-cells by causing a redox imbalance. J Biochem, 126:41-7.
185. Huang M, Joseph JW (2012). Metabolomic analysis of pancreatic ß-cell insulin release in response to glucose. Islets, 4:210-22.
186. Taylor-Fishwick DA (2013), NOX, NOX Who is There? The Contribution of NADPH Oxidase One to Beta Cell Dysfunction. Front Endocrinol (Lausanne), 4:40.
187. Lu X, Liu J, Hou F, Liu Z, Cao X, Seo H, Gao B (2011). Cholesterol induces pancreaticß cell apoptosis through oxidative stress pathway. Cell Stress Chaperones, 16:539-48.
188. Chang KC, Hsu CC, Liu SH, Su CC, Yen CC, Lee MJ, Chen KL, Ho TJ, Hung DZ, Wu CC, Lu TH, Su YC, Chen YW, Huang CF (2013). Cadmium induces apoptosis in pancreatic ß-cells through a mitochondria-dependent pathway: the role of oxidative stress-mediated c-Jun N-terminal kinase activation. PloS One, 8:e54374.
189. Subramanian SL, Hull RL, Zraika S, Aston-Mourney K, Udayasankar J, Kahn SE (2012). cJun N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets. Diabetologia, 55:166-74.
190. Lombardi A, Ulianich L, Treglia AS, Nigro C, Parrillo L, Lofrumento DD, Nicolardi G, Garbi C, Beguinot F, Miele C, DiJeso B (2012). Increased hexosamine biosynthetic pathway flux dedifferentiates INS-1E cells and murine islets by anextra cellular signal-regulated kinase (ERK)1/2-mediated signal transmission pathway. Diabetologia, 55:141-53.
191. Ježek P, Dlasková A, Plecitá-Hlavatá L (2012). Redox homeostasis in pancreatic ß cells. Oxid Med Cell Longev, 2012:932838.
192. Liu D, Pavlovic D, Chen MC, Flodström M, Sandler S, Eizirik DL (2000). Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes, 49:1116-22.
193. Azevedo-Martins AK, Lortz S, Lenzen S, Curi R, Eizirik DL, Tiedge M (2003). Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappa B activation in insulin-producing cells. Diabetes, 52:93-101.
194. Padgett LE, Broniowska KA, Hansen PA, Corbett JA, Tse HM (2013). The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Ann N Y Acad Sci, 1281:16-35.
195. Dai X, Ding Y, Zhang Z, Cai X, Li Y (2013). Quercetin and quercitrin protect against cytokine induced injuries in RINm5F ß-cells via the mitochondrial pathway and NF-?B signaling. Int J Mol Med, 31:265-71.
196. Ding Y, Zhang ZF, Dai XQ, Li Y (2012). Myricetin protects against cytokine-induced cell death in RIN-m5f ß cells. J Med Food, 15:733-40.
197. Lin CY, Ni CC, Yin MC, Lii CK (2012). Flavonoids protect pancreatic beta-cells from cytokines mediated apoptosis through the activation of PI3-kinase pathway. Cytokine, 59(1):65-71.
198. Vander Loo B, Labugger R, Skepper JN, Bachschmid M, Kilo J, Powell JM, Palacios-Callender M, Erusalimsky JD, Quaschning T, Malinski T, Gygi D, Ullrich V, Lüscher TF (2000). Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med, 192:1731-44.
199. Donato AJ, Eskurza I, Silver AE, Levy AS, Pierce GL, Gates PE, Seals DR (2007). Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappa B. Circ Res, 100:1659-66.
200. Smith AR, Visioli F, Frei B, Hagen TM (2006). Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A. Aging Cell, 5:391-400.
201. LeBlanc AJ, Shipley RD, Kang LS, Muller-Delp JM (2008). Age impairs Flk-1 signaling and NO-mediated vasodilation in coronary arterioles. Am J Physiol Heart Circ Physiol, 295:H2280-8.
202. Altan VM, Karasu C, Ozüari A (1989). The effects of type-1 and type-2 diabetes on endothelium-dependent relaxation in rat aorta. Pharmacol Biochem Behav, 33:519-22.
203. Karasu C, Altan VM (1993). The role of endothelial cells on the alterations in vascular reactivity induced by insulin-dependent diabetes mellitus: effects of insulin treatment. Gen Pharmacol, 24:743-55.
204. Karasu C, Altan VM (1994). The role of the endothelium on enhanced contractile response of non-insulin-dependent diabetic rat aortae: effects of insulin treatment. Gen Pharmacol, 25:795-802.
205. Karasu C, Soncul H, Altan VM (1995). Effects of non-insulin dependent diabetes mellitus on the reactivity of human internal mammary artery and human saphenous vein. Life Sci, 57:103-12.
206. Karasu C (1999). Increased activity of H2O2 in aorta isolated from chronically streptozotocin-diabetic rats: effects of antioxidant enzymes and enzymes inhibitors. Free Radic Biol Med, 27:16-27.
207. Bauer V, Sotníková R, Drábiková K (2011). Effects of reactive oxygen species and neutrophils on endothelium-dependent relaxation of rat thoracic aorta. Interdiscip Toxicol, 4:191-7.
208. Zobali F, Cakici I, Karasu C (2001). Effects of peroxynitrite on the reactivity of diabetic rat aorta. Pharmacology, 63:58-64.
209. Karasu C (2000). Time course of changes in endothelium-dependent and-independent relaxation of chronically diabetic aorta: role of reactive oxygen species. Eur J Pharmacol, 392:163-73.
210. Zobali F, Besler T, Ari N, Karasu C (2002). (Antioxidants in Diabetes-Induced Complications) TheADIC Study Group. Hydrogen peroxide-induced inhibition of vasomotor activity: evaluation of single and combined treatments with vitamin A and insulin in streptozotocin-diabetic rats. Int J Exp Diabetes Res, 3:119-30.
211. Michan S, Sinclair D (2007). Sirtuins in mammals: insights into their biological function. Biochem J, 404:1-13.
212. Finkel T, Deng CX, Mostoslavsky R (2009). Recent progress in the biology and physiology of sirtuins. Nature, 460(7255):587-91.
213. Rodríguez-Mañas L, El-Assar M, Vallejo S, López-Dóriga P, Solís J, Petidier R, Montes M, Nevado J, Castro M, Gómez-Guerrero C, Peiró C, Sánchez-Ferrer CF (2009). Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation. Aging Cell, 8:226-38.
214. Barona J, Aristizabal JC, Blesso CN, Volek JS, Fernandez ML. Grape polyphenols reduce blood pressure and increase flow-mediated vasodilation in men with metabolic syndrome. J nutr, 142:1626-32.
215. Landberg R, Naidoo N, van Dam RM (2012). Diet and endothelial function: from individual components to dietary patterns. Curr Opin Lipidol, 23:147-55.
216. Chong MF, Macdonald R, Lovegrove JA (2010). Fruit polyphenols and CVD risk: a review of human intervention studies. Br J Nutr, 104(Supplement 3):S28-39.
217. Ghosh D, Scheepens A (2009). Vascular action of polyphenols. Mol Nutr Food Res, 53:322-31.
218. Mulvihill EE, Huff MW (2010). Antiatherogenic properties of flavonoids: implications for cardiovascular health. Can J Cardiol, 26(Supplement A):17A-21A.
219. Yubero-Serrano EM, Garcia-Rios A, Delgado-Lista J, Delgado-Casado N, Perez-Martinez P, Rodriguez-Cantalejo F, Fuentes F, Cruz-Teno C, Tunez I, Tasset-Cuevas I, Tinahones FJ, Perez-Jimenez F, Lopez-Miranda J (2011). Postprandial effects of the Mediterranean diet on oxidant and antioxidant status in elderly men and women. J Am Geriatr Soc, 59:938-40.
220. Perez-Martinez P, Garcia-Quintana JM, Yubero-Serrano EM, Tasset-Cuevas I, Tunez I, Garcia-Rios A, Delgado-Lista J, Marin C, Perez-Jimenez F, Roche HM, Lopez-Miranda J (2010). Postprandial oxidative stress is modified by dietary fat: evidence from a human intervention study. Clin Sci (Lond), 119:251-61.
221. Peña-Orihuela P, Camargo A, Rangel-Zuñiga OA, Perez-Martinez P, Cruz-Teno C, Delgado-Lista J, Yubero-Serrano EM, Paniagua JA, Tinahones FJ, Malagon MM, Roche HM, Perez-Jimenez F, Lopez-Miranda J (2013). Antioxidant system response is modified by dietary fat in adipose tissue of metabolic syndrome patients. J Nutr Biochem. In Press.
222. Scoditti E, Calabriso N, Massaro M, Pellegrino M, Storelli C, Martines G, DeCaterina R, Carluccio MA (2012). Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch Biochem Biophys, 527:81-9.
223. Cruz-Teno C, Pérez-Martínez P, Delgado-Lista J, Yubero-Serrano EM, García-Ríos A, Marín C, Gómez P, Jiménez-Gómez Y, Camargo A, Rodríguez-Cantalejo F, Malagón MM, Pérez-Jiménez F, Roche HM, López-Miranda J (2012). Dietary fat modifies the postprandial inflammatory state in subjects with metabolic syndrome: the LIPGENE study. Mol Nutr Food Res, 56:854-65.
224. Yubero-Serrano EM, Gonzalez-Guardia L, Rangel-Zuñiga O, Delgado-Casado N, Delgado-Lista J, Perez-Martinez P, Garcia-Rios A, Caballero J, Marin C, Gutierrez-Mariscal FM, Tinahones FJ, Villalba JM, Tunez I, Perez-Jimenez F, Lopez-Miranda J (2013). Postprandial antioxidant gene expression is modified by Mediterranean diet supplemented with coenzyme Q(10) in elderly men and women. Age (Dordr), 35:159-70.
225. Aires DJ, Rockwell G, Wang T, Frontera J, Wick J, Wang W, Tonkovic-Capin M, Lu J, E L, Zhu H, Swerdlow RH (2012). Potentiation of dietary restriction-induced lifespan extension by polyphenols. Biochim Biophys Acta, 1822:522-6.